US2008171731A1PendingUtilityA1

Prevention of ovarian cancer by administration of a vitamin d compound

69
Individually held — no corporate assignee on recordPriority: Jun 11, 1997Filed: Oct 31, 2007Published: Jul 17, 2008
Est. expiryJun 11, 2017(expired)· nominal 20-yr term from priority
Inventors:Gustavo Rodriguez
A61K 31/56A61K 31/565A61K 31/59A61K 31/57A61P 35/00A61K 31/593
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical product for hormone replacement therapy comprising 25 daily sequential dosages, with each daily sequential dosage comprising an estrogen product and with at least one of said daily sequential dosages further comprising a Vitamin D compound at a dosage of at least 400 IU.

Join the waitlist — get patent alerts

Track US2008171731A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.